Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

23.76
Delayed Data
As of Jun 15
 -0.02 / -0.08%
Today’s Change
10.85
Today|||52-Week Range
33.82
+25.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues6.0B5.8B5.6B5.2B
 
 
 
 
 
Cost of Goods Sold2.4B2.5B2.6B2.3B
 
 
 
 
 
Depreciation And Amortization607.5M587.2M386.7M516.5M
 
 
 
 
 
 
Operating ExpensesGross Income3.0B2.7B2.6B2.4B
 
 
 
 
 
General Expenses1.8B1.8B1.8B1.4B
 
 
 
 
 
Other Operating Expenses0.000.000.0020.4M
 
 
Research And Development511.7M562.5M370.2M323.0M
 
 
 
 
 
Total Operating Expenses4.8B4.9B4.8B4.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.2B937.1M848.5M928.1M
 
 
 
 
 
Extraordinary Credit4.2M24.8M85.4M1.3B
 
 
 
 
 
Extraordinary Charge-7.2B-560.4M-15.0B-909.8M
 
 
 
 
 
Interest Expense On Debt241.1M267.3M172.8M249.6M
 
 
 
 
 
Equity In Earnings-14.7M-3.1M7.2M-75.4M
 
 
 
 
 
Other Expenses-5.3M-11.4M698.3M206.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.3B122.8M-13.6B1.3B
 
 
 
 
 
Income Taxes-23.2M-509.8M-1.5B-46.9M
 
 
 
 
 
Minority Interest---15.5M-200.5M-14.3M
 
 
 
 
Preferred Dividend-68.4M-67.1M-66.8M-66.2M
 
 
 
 
 
Net Income-6.3B614.1M-11.9B1.1B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.0B1.0B1.0B1.0B
 
 
 
 
 
Shares To Calculate EPS Diluted1.0B1.0B1.0B1.0B
 
 
 
 
 
 
Earnings Per ShareEPS-$6.25$0.54-$11.73$1.06
 
 
 
 
 
EPS Diluted-$6.24$0.54-$11.73$1.05